Projects

MUDr. RNDr. Angelika Púzserová, PhD.

International

Current
  • Bridging the gap between cardiac and vascular regeneration
    Program: Horizon Europe
    Duration: 1. 1. 2024 – 31. 12. 2026
Finished
  • Stress-induced pressor responses: endothelial factors vs. central regulation of sympathetic tone
    Program: Inter-academic agreement
    Duration: 1. 1. 2016 – 31. 12. 2017
  • Effect of natural polyphenols on the development and maintenance of experimental hypertension and remodelling of cardiovascular system
    Program: Inter-institute agreement
    Duration: 1. 10. 2004 – 30. 9. 2013

National

Current
  • New aspects of cardioprotection by natural antioxidants: role of ageing and lifestyle-related comorbidities
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • Biomarkers of endothelial dysfunction and erythrocyte characteristics in patients with long COVID
    Program:
    Duration: 1. 1. 2025 – 31. 12. 2025
Finished
  • Hyperuricemia in various comorbidities of the metabolic syndrome - mechanisms of the effect of uric acid on endothelial function and erythrocyte deformability.
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Research of magnetic forms of iron in development of cardiovascular diseases and behavioural disorders
    Program: SRDA
    Duration: 1. 7. 2017 – 30. 6. 2021
  • Mechanisms involved in uric acid-induced endothelial dysfunction depending on the age and genetic predisposition to hypertension
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • Effect of ultrasmall superparamagnetic iron oxide nanoparticles on the cardiovascular system of rats with high blood pressure
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • New regulatory effects of nitric oxide and their role in the development of essential hypertension
    Program: SRDA
    Duration: 1. 7. 2016 – 30. 6. 2020
  • Protection of mechanisms modulating endothelial permeability in the heart.
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Effect of aging on the endothelial function in experimental hypertension
    Program: Other projects
    Duration: 17. 4. 2014 – 17. 4. 2017
  • Epicatechin in prevention of early development of primary hypertension: mechanisms of action in the cardiovascular and central nervous systems
    Program: VEGA
    Duration: 1. 1. 2014 – 31. 12. 2016
  • Effect of PPAR gamma agonists on antioxidant response and on regulation of radical and cell signaling in hypertension
    Program: VEGA
    Duration: 1. 1. 2014 – 31. 12. 2016
  • Yeasts in protection of endothelial intercellular connections against inflammation-induced injury.
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2015
  • Gender differences in etiopathogenesis of social stress-related cardiovascular and behavioral disorders in individuals with predisposition to hypertension
    Program: SRDA
    Duration: 1. 5. 2011 – 30. 10. 2014
  • Social stress as a risk factor of early development of hypertension in predisposed individuals
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2013
  • Centre of Excellence for Research and Development of Constructive Composite Materials II
    Program: EU Structural Funds Research & Development
    Duration: 1. 9. 2009 – 30. 6. 2013
  • Antiinflammatory protection of intercellular communication of cardiovascular system.
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2012
  • Hypertension and diabetes as the parts of metabolic syndrome: the effects of antioxidant therapy
    Program: SRDA
    Duration: 1. 6. 2008 – 31. 12. 2010
  • Long-term administration of low dose of L-NAME: Possibility to improve function of vessel wall in border hypertension?
    Program: VEGA
    Duration: 1. 1. 2007 – 31. 12. 2009
  • Long-term low dose L-NAME treatment:Possibility to improve the vascular function in borderline hypertension?
    Program: VEGA
    Duration: 1. 1. 2007 – 31. 12. 2009
  • Morphological and molecular changes of tissues as result of cellular damage in decompression sickness
    Program: VEGA
    Duration: 1. 1. 2007 – 31. 12. 2008
  • Role of bioflavonoids in prevention of social stress-induced hypertension
    Program: SRDA
    Duration: 1. 1. 2005 – 31. 12. 2007
  • The interaction of stress and genetic factors in the etiology of high blood pressure and behavioral failure: the role of nitric oxide
    Program: VEGA
    Duration: 1. 1. 2004 – 31. 12. 2006
Employees